Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy
- DOI
- 10.1111/bcp.13920
- Published
- 2019-05-17
- Container
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bcp.13920,
title = {Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy},
author = {Candice Jamois and Ekaterina Gibiansky and Leonid Gibiansky and Vincent Buchheit and Denis Sahin and Guillaume Cartron and Robert Marcus and Wolfgang Hiddemann and John F. Seymour and Jonathan C. Strefford and Chantal E. Hargreaves and Georgina Meneses‐Lorente and Nicolas Frey and Günter Fingerle‐Rowson},
year = {2019},
journal = {British Journal of Clinical Pharmacology},
doi = {10.1111/bcp.13920},
url = {https://doi.org/10.1111/bcp.13920}
}RIS
TY - JOUR TI - Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy AU - Candice Jamois AU - Ekaterina Gibiansky AU - Leonid Gibiansky AU - Vincent Buchheit AU - Denis Sahin AU - Guillaume Cartron AU - Robert Marcus AU - Wolfgang Hiddemann AU - John F. Seymour AU - Jonathan C. Strefford AU - Chantal E. Hargreaves AU - Georgina Meneses‐Lorente AU - Nicolas Frey AU - Günter Fingerle‐Rowson PY - 2019 JO - British Journal of Clinical Pharmacology DO - 10.1111/bcp.13920 UR - https://doi.org/10.1111/bcp.13920 ER -
APA
Jamois, C., Gibiansky, E., Gibiansky, L., Buchheit, V., Sahin, D., Cartron, G., Marcus, R., Hiddemann, W., Seymour, J. F., Strefford, J. C., Hargreaves, C. E., Meneses‐Lorente, G., Frey, N., & Fingerle‐Rowson, G. (2019). Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.13920
Source records
- crossref · retrieved 2026-09-26T22:28:09.678Z